Condition
Metabolic Diseases
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 52 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
52 shownMETabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)NCT07699380 · 2026-09-01
RECRUITINGEarly Pregnancy Lifestyle and Glucose Patterns: A Substudy of TOFFFYNCT07534670 · 2026-05-01
RECRUITINGMyokines as Potential Biomarkers and Drivers of Sarcopenia in Metabolic and Endocrine DiseasesNCT07703683 · 2026-02-19
RECRUITINGEffect of Low Valine Diet on Body Weight and Metabolic ParametersNCT06883578 · 2025-02-18
RECRUITINGClinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUsNCT06674980 · 2024-12-20
RECRUITINGEffects of HIIT vs. TRE on Type 2 Diabetes RiskNCT07215533 · 2024-03-15
RECRUITINGGLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGHNCT06003153 · 2024-03-12
RECRUITINGCardiometabolic evalUation REgistry of Heart FailureNCT06939985 · 2015-01-01
RECRUITINGSpecificities of Atypical Non AutoImmune Diabetes (ANAID) in the French West IndiesNCT07576374 · 2026-06-01
NOT_YET_RECRUITINGThe Efficacy and Safety of Puerarin in Obesity TreatmentNCT06968208 · 2025-08-01
NOT_YET_RECRUITINGFinancial Navigation and Peer Support to Improve Diabetes OutcomesNCT06619834 · 2025-02-11
COMPLETEDComparing Dumping Symptoms and Quality of Life 6 Months After Sleeve Gastrectomy With or Without Transit Bipartition in Adults With ObesityNCT07263269 · 2024-04-06
ACTIVE_NOT_RECRUITINGValidate Smart Breath Analyzer as Screening Tool for Diabetic, Hepatic, Renal, Lung, and Other Metabolic DisordersNCT07646015 · 2022-10-03
COMPLETEDDigital Foot Self-Management Program for Older-DiabetesNCT05272670 · 2022-02-15
UNKNOWNThe Effects of Freshwater Clam Extract on Blood Sugar, and Lipid Profile in Prediabetes PatientsNCT04429737 · 2017-03-01
UNKNOWNImpact of Meal Order on Postprandial Cardiometabolic Risk MarkersNCT03358745 · 2016-06-01
COMPLETEDExercise Snacks and Glutamine to Improve Glucose Control in Adolescents With Type 1 DiabetesNCT03199638 · 2016-04-01
COMPLETEDIntestinal Metabolic Reprogramming as a Key Mechanism of Gastric Bypass in HumansNCT02710370 · 2016-02-01
ACTIVE_NOT_RECRUITINGEpigenetic Mechanisms and Severe Obesity (Biological Tissue Collection)NCT02663388 · 2016-01-01
UNKNOWNWhey Protein Effect on Glycaemic and Appetite Responses in T2DNCT02903199 · 2015-07-01
UNKNOWNNutrition and Energy Restriction for Cancer PreventionNCT02449148 · 2015-05-01
COMPLETEDFollow-up Study of Complications of Acute PancreatitisNCT02305914 · 2014-11-01
UNKNOWNComparison of A New Technique of Measure of the Insulin Resistance By Scintigraphy With the Reference TechniqueNCT02102737 · 2014-05-13
COMPLETEDIntestinal Permeability in ObesityNCT02292121 · 2014-02-24
TERMINATEDTransplantation of Autologous Stem Cells for the Treatment of Type 1 Diabetes MellitusNCT02644759 · 2014-02-01
COMPLETEDComparison of a Plant Protein Diet to a Animal Protein Diet Emphasized in Type 2 DiabeticsNCT02402985 · 2013-09-01
COMPLETEDDiet, Physical Activity and Breastfeeding Intervention on Maternal Nutrition, Offspring Growth and DevelopmentNCT01916603 · 2013-09-01
UNKNOWNPharmacokinetics Study of Gamma-aminobutyric AcidNCT01917760 · 2013-07-01
COMPLETEDThe Fasting II StudyNCT01792986 · 2013-02-01
COMPLETEDAdipose Tissue and Polycystic Ovary Syndrome (PCOS)(EIFFEL)NCT01745471 · 2012-12-06
ACTIVE_NOT_RECRUITINGFibrosis a New Pathological Actor in Adipose TissueNCT01655017 · 2012-02-08
COMPLETEDComparative Bioavailability - Gender Effect - Single and Multiple Ascending Dose Safety and Pharmacokinetic Study of GFT505NCT01474161 · 2011-11-01
COMPLETEDEffect of Caloric Restriction on Fat Oxidation in Obese Men and Women (Magellan II)NCT01616082 · 2011-09-01
COMPLETEDIntervening in Diabetes With Healthy Eating, Activity, and Linkages To Healthcare - The I-D-HEALTH StudyNCT01435603 · 2011-08-01
COMPLETEDAdaptation of Human Gut Microbiota to Energetic RestrictionNCT01454232 · 2011-06-07
COMPLETEDSingle-Dose And Multiple-Dose Safety And Tolerability Study Of PF-04856883 In Type 2 Diabetic Adult FemalesNCT01301456 · 2011-03-01
COMPLETEDA Comparative Clinical Trial of the TensorTip, a Novel Non Invasive Device for Measurement Blood ParametersNCT01196533 · 2010-08-01
COMPLETEDOPTIFIT-Optimal Fiber Trial for Diabetes PreventionNCT01681173 · 2010-05-01
COMPLETEDAldosterone and the Metabolic SyndromeNCT01103245 · 2010-03-01
COMPLETEDEffect of Fish Oil (Omega-3 Fatty Acids) on ArteriesNCT00935766 · 2009-09-01
TERMINATEDA Study of the Safety of R256918 in Obese PatientsNCT01041677 · 2008-02-01
COMPLETEDA Study of the Safety and Effectiveness of JNJ-16269110 (R256918) in Overweight and Obese PatientsNCT00622765 · 2007-11-01
COMPLETEDRespiratory Health of Elite AthletesNCT00686491 · 2007-06-01
COMPLETEDChung-ju Metabolic Disease Cohort (CMC) StudyNCT00707668 · 2007-05-01
UNKNOWNEffectiveness of Nucleoside Supplementation or Switch to Tenofovir in Reversing Fat Loss in HIV Infected AdultsNCT00119379 · 2005-04-01
COMPLETEDObservational Study of Fat Loss in HIV Infected Adults Taking Nucleoside Reverse Transcriptase Inhibitors (NRTIs)NCT00119405 · 2005-04-01
COMPLETEDEducation, Counseling, and Drug Therapy to Reduce Symptoms of Metabolic SyndromeNCT00129792 · 2005-01-01
COMPLETEDSeronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy SubjectsNCT00192621 · 2004-11-01
COMPLETEDChromium Picolinate for the Treatment of Metabolic SyndromeNCT00128154 · 2004-01-01
COMPLETEDStudy of Lifestyle Modification in HIV LipodystrophyNCT00111358 · 2003-06-01
COMPLETEDIslet Allotransplantation With Steroid Free ImmunosuppressionNCT00446264 · 2003-05-01
COMPLETEDImpact of Peer Support on Diabetes in ChinaNCT02119572
UNKNOWNCommon interventions
PlaceboDRUG6PlaceboDIETARY_SUPPLEMENT3R256918DRUG26-DIGDRUG1A digital foot self-management programBEHAVIORAL1a solution of mannitol and lactitolOTHER1adipose tissue biopsyOTHER1Advice Plus Lifestyle InterventionBEHAVIORAL1AI-based dietary and meal timing logging mobile applicationBEHAVIORAL1Aliskiren 150 mg (ALI 150)DRUG1Aliskiren 300 mg (ALI 300)DRUG1AM/Double - DFUOTHER1AM/Double - VLUOTHER1AM/Single - DFUOTHER1AM/Single - VLUOTHER1AMX0035DRUG1biopsyPROCEDURE1Calorie RestrictionOTHER1Chromium picolinateDRUG1Clam peptide plus Chlorella capsulesDIETARY_SUPPLEMENT1clam protein capsulesDIETARY_SUPPLEMENT1clampPROCEDURE1Combivir (zidovudine [AZT] / lamivudine [3TC])DRUG1Continuous glucose monitor (CGM)DEVICE1daclizumab - sirolimus - tacrolimusDRUG1
Leading sponsors
Assistance Publique - Hôpitaux de Paris
3
AdventHealth Translational Research Institute
2
German Institute of Human Nutrition
2
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
2
Massachusetts General Hospital
2
National Institute of Allergy and Infectious Diseases (NIAID)
2
Ruijin Hospital
2
C5 Biomedical
1
Centre Hospitalier Universitaire de la Guadeloupe
1
Chang Gung Memorial Hospital
1
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
1
Cnoga Medical Ltd.
1
Denver Health and Hospital Authority
1
Fooyin University
1
Genfit
1
Trial status mix
COMPLETED29
RECRUITING8
UNKNOWN8
ACTIVE_NOT_RECRUITING3
NOT_YET_RECRUITING2
TERMINATED2
Phase mix
NA26
PHASE28
PHASE14
PHASE42
PHASE31
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.